IL-27 counteracts neuropathic pain development through induction of IL-10 (2020)
Source: Frontiers in Immunology. Unidade: FMRP
Subjects: BIOMARCADORES, CITOCINAS, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, GÂNGLIOS, INTERLEUCINA 10, MEDULA ESPINHAL
ABNT
FONSECA, Miriam das Dores Mendes et al. IL-27 counteracts neuropathic pain development through induction of IL-10. Frontiers in Immunology, v. 10, 2020Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.03059. Acesso em: 12 nov. 2024.APA
Fonseca, M. das D. M., Davoli-Ferreira, M., Santa-Cecília, F., Guimarães, R. M., Oliveira, F. F. B., Kusuda, R., et al. (2020). IL-27 counteracts neuropathic pain development through induction of IL-10. Frontiers in Immunology, 10. doi:10.3389/fimmu.2019.03059NLM
Fonseca M das DM, Davoli-Ferreira M, Santa-Cecília F, Guimarães RM, Oliveira FFB, Kusuda R, Ferreira DW, Alves Filho JCF, Cunha F de Q, Cunha TM. IL-27 counteracts neuropathic pain development through induction of IL-10 [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2024 nov. 12 ] Available from: https://doi.org/10.3389/fimmu.2019.03059Vancouver
Fonseca M das DM, Davoli-Ferreira M, Santa-Cecília F, Guimarães RM, Oliveira FFB, Kusuda R, Ferreira DW, Alves Filho JCF, Cunha F de Q, Cunha TM. IL-27 counteracts neuropathic pain development through induction of IL-10 [Internet]. Frontiers in Immunology. 2020 ; 10[citado 2024 nov. 12 ] Available from: https://doi.org/10.3389/fimmu.2019.03059